Chemoinformaics analysis of 1,3,8-trihydroxy-5-methoxy xanthone
| Molecular Weight | 274.228 | nRot | 1 |
| Heavy Atom Molecular Weight | 264.148 | nRig | 17 |
| Exact Molecular Weight | 274.048 | nRing | 3 |
| Solubility: LogS | -3.584 | nHRing | 1 |
| Solubility: LogP | 2.401 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 34.8599 |
| nHD | 3 | BPOL | 14.3721 |
| QED | 0.587 |
| Synth | 2.45 |
| Natural Product Likeliness | 1.688 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.319 |
| HIA | 0.036 |
| CACO-2 | -4.956 |
| MDCK | 0.00000901 |
| BBB | 0.008 |
| PPB | 0.918757 |
| VDSS | 0.901 |
| FU | 0.12447 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.905 |
| CYP2c19-inh | 0.12 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.633 |
| CYP2c9-sub | 0.929 |
| CYP2d6-inh | 0.573 |
| CYP2d6-sub | 0.492 |
| CYP3a4-inh | 0.314 |
| CYP3a4-sub | 0.112 |
| CL | 7.692 |
| T12 | 0.87 |
| hERG | 0.005 |
| Ames | 0.706 |
| ROA | 0.104 |
| SkinSen | 0.866 |
| Carcinogencity | 0.072 |
| EI | 0.933 |
| Respiratory | 0.283 |
| NR-Aromatase | 0.833 |
| Antiviral | Yes |
| Prediction | 0.68611 |